These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 25929447

  • 1. Ellagic Acid, a Dietary Polyphenol, Inhibits Tautomerase Activity of Human Macrophage Migration Inhibitory Factor and Its Pro-inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
    Sarkar S, Siddiqui AA, Mazumder S, De R, Saha SJ, Banerjee C, Iqbal MS, Adhikari S, Alam A, Roy S, Bandyopadhyay U.
    J Agric Food Chem; 2015 May 27; 63(20):4988-98. PubMed ID: 25929447
    [Abstract] [Full Text] [Related]

  • 2. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
    Spencer ES, Dale EJ, Gommans AL, Rutledge MT, Vo CT, Nakatani Y, Gamble AB, Smith RA, Wilbanks SM, Hampton MB, Tyndall JD.
    Eur J Med Chem; 2015 Mar 26; 93():501-10. PubMed ID: 25743213
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity suppresses microglia-mediated inflammatory responses.
    Zhang Y, Gu R, Jia J, Hou T, Zheng LT, Zhen X.
    Clin Exp Pharmacol Physiol; 2016 Nov 26; 43(11):1134-1144. PubMed ID: 27543936
    [Abstract] [Full Text] [Related]

  • 4. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
    Taylor AB, Johnson WH, Czerwinski RM, Li HS, Hackert ML, Whitman CP.
    Biochemistry; 1999 Jun 08; 38(23):7444-52. PubMed ID: 10360941
    [Abstract] [Full Text] [Related]

  • 5. Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.
    Chuang CC, Chuang YC, Chang WT, Chen CC, Hor LI, Huang AM, Choi PC, Wang CY, Tseng PC, Lin CF.
    BMC Immunol; 2010 Oct 12; 11():50. PubMed ID: 20939898
    [Abstract] [Full Text] [Related]

  • 6. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
    Dickerhof N, Schindler L, Bernhagen J, Kettle AJ, Hampton MB.
    Free Radic Biol Med; 2015 Dec 12; 89():498-511. PubMed ID: 26453918
    [Abstract] [Full Text] [Related]

  • 7. Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
    Trivedi-Parmar V, Robertson MJ, Cisneros JA, Krimmer SG, Jorgensen WL.
    ChemMedChem; 2018 Jun 06; 13(11):1092-1097. PubMed ID: 29575754
    [Abstract] [Full Text] [Related]

  • 8. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
    Orita M, Yamamoto S, Katayama N, Fujita S.
    Curr Pharm Des; 2002 Jun 06; 8(14):1297-317. PubMed ID: 12052220
    [Abstract] [Full Text] [Related]

  • 9. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
    Vera PL, Iczkowski KA, Howard DJ, Jiang L, Meyer-Siegler KL.
    Neurourol Urodyn; 2010 Nov 06; 29(8):1451-7. PubMed ID: 20127836
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
    Garai J, Molnár V, Eros D, Orfi L, Lóránd T.
    Int Immunopharmacol; 2007 Dec 15; 7(13):1741-6. PubMed ID: 17996684
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
    Sugimoto H, Taniguchi M, Nakagawa A, Tanaka I, Suzuki M, Nishihira J.
    Biochemistry; 1999 Mar 16; 38(11):3268-79. PubMed ID: 10079069
    [Abstract] [Full Text] [Related]

  • 15. Irregularities in enzyme assays: The case of macrophage migration inhibitory factor.
    Cisneros JA, Robertson MJ, Valhondo M, Jorgensen WL.
    Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2764-2767. PubMed ID: 27156768
    [Abstract] [Full Text] [Related]

  • 16. Human single-chain variable fragment antibody inhibits macrophage migration inhibitory factor tautomerase activity.
    Tarasuk M, Poungpair O, Ungsupravate D, Bangphoomi K, Chaicumpa W, Yenchitsomanus PT.
    Int J Mol Med; 2014 Mar 15; 33(3):515-22. PubMed ID: 24424397
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.
    Wang FF, Zhu LA, Zou YQ, Zheng H, Wilson A, Yang CD, Shen N, Wallace DJ, Weisman MH, Chen SL, Lu LJ.
    Arthritis Res Ther; 2012 May 02; 14(3):R103. PubMed ID: 22551315
    [Abstract] [Full Text] [Related]

  • 19. Vitamin E is a MIF Inhibitor.
    Hegde B, Vadnal P, Sanghavi J, Korde V, Kulkarni-Almeida AA, Dagia NM.
    Biochem Biophys Res Commun; 2012 Feb 10; 418(2):384-9. PubMed ID: 22281490
    [Abstract] [Full Text] [Related]

  • 20. NF-kappaB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells.
    Cho ML, Moon YM, Heo YJ, Woo YJ, Ju JH, Park KS, Kim SI, Park SH, Kim HY, Min JK.
    Immunol Lett; 2009 Mar 24; 123(1):21-30. PubMed ID: 19428548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.